cancer

Hyundai Hope on Wheels has awarded nearly $2.8 million to support Dr. Steven Jonas’ research at UCLA.

Millions are alive today because of leukemia therapies that arose from Owen Witte’s UCLA research, including retired Army Maj. Melvin Mann.

The clinical trial demonstrates that combining genetically engineered T cells and stem cells can produce cancer-fighting immune cells in humans.

UCLA captured U.S. News & World Report's No. 1 ranking for hospital-based care in L.A. and California and made the publication’s Honor Roll for the 36th straight year.

Researchers outline how screening, equity and policy can save more lives from colorectal cancer.

Researchers are working to launch a first-in-human clinical trial to test the approach.

Researchers found that very small elevations in two biomarkers are strong and independent predictors of overall cancer risk.

The algorithm unlocks the full potential of proteogenomics by overcoming a key challenge in linking genetic mutations to protein-level changes.

Jung, who will deliver UCLA’s 130th Faculty Research Lecture, explains how he developed cancer-fighting drugs.

A widely prescribed drug boosted the ability of T cells to fight cancer and suppressed growth in mouse and human tumor models.

UCLA researchers looked at how using MRI, MRI-guided biopsies and focal therapy can help men with prostate cancer remain on active surveillance.

Using artificial intelligence during routine screening could flag spots of concern invisible to the naked eye.

Firefighters have a 9% higher risk of a cancer diagnosis and a 14% higher risk of dying from cancer compared with the general population.

A team led by UCLA Health Jonsson Comprehensive Cancer Center doctors Dennis Slamon and Richard Finn, helped transform breast cancer treatment.

Lab studies find UCLA-developed nanoparticle triggers killer cells and memory cells to fight often-lethal migration.

A UCLA team is working to create a therapy designed to both eliminate cancer cells and dismantle the tumor’s protective defenses.

UCLA researchers combined radiation therapy with a plant-derived compound to force glioblastoma cells into a dormant state.

With pioneering treatments, research and outreach, UCLA's health-centered approach is becoming a national model.

Chemotherapy can affect appetite and digestion, so preparation and flexibility are key.

Simulations reveal PAHs’ affinity for binding to DNA — and evading repair — in study co-led by a county firefighter.

Immune-based treatment gets a boost to its cancer-fighting superpowers.

It’s here. It’s going to change life as we know it. Are you ready? Are you sure?

Using small 3D models that mimic a patient’s tumor, UCLA researchers can quickly test hundreds of potential drugs.

A new study suggests combination therapies could overcome tumor adaptability.

A minimally invasive approach gives a better treatment option to certain patients with metastatic uveal melanoma.